Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States

HA Gans, J Ren, LL Yasukawa… - The Journal of …, 2004 - academic.oup.com
Background. Shifts in peak measles incidence to children< 12 months old and the
associated high mortality support the study of an early 2-dose measles vaccine regimen …

Humoral and Cell-Mediated Immune Responses to an Early 2-Dose Measles Vaccination Regimen in the United States.

HA Gans, LL Yasukawa, A Alderson… - Journal of Infectious …, 2004 - search.ebscohost.com
Background. Shifts in peak measles incidence to children &lt; 12 months old and the
associated high mortality support the study of an early 2-dose measles vaccine regimen …

Humoral and Cell-Mediated Immune Responses to an Early 2-Dose Measles Vaccination Regimen in the United States

HA Gans, LL Yasukawa, A Alderson, M Rinki… - The Journal of Infectious …, 2004 - JSTOR
Background. Shifts in peak measles incidence to children< 12 months old and the
associated high mortality support the study of an early 2-dose measles vaccine regimen …

[引用][C] Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States

HA GANS, LL YASUKAWA… - The Journal of …, 2004 - pascal-francis.inist.fr
Humoral and cell-mediated immune responses to an early 2-dose measles vaccination
regimen in the United States CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States

HA Gans, LL Yasukawa, A Alderson… - The Journal of …, 2004 - pubmed.ncbi.nlm.nih.gov
Background Shifts in peak measles incidence to children< 12 months old and the associated
high mortality support the study of an early 2-dose measles vaccine regimen. Methods Fifty …

Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.

HA Gans, LL Yasukawa, A Alderson… - The Journal of …, 2004 - europepmc.org
Background Shifts in peak measles incidence to children< 12 months old and the associated
high mortality support the study of an early 2-dose measles vaccine regimen. Methods Fifty …

Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.

HA Gans, LL Yasukawa, A Alderson, M Rinki… - 2004 - cabidigitallibrary.org
Background. Shifts in peak measles incidence to children< 12 months old and the
associated high mortality support the study of an early 2-dose measles vaccine regimen …

[PDF][PDF] Humoral and Cell-Mediated Immune Responses to an Early 2-Dose Measles Vaccination Regimen in the United States

HA Gans, LL Yasukawa, A Alderson… - The Journal of …, 2004 - academia.edu
Background. Shifts in peak measles incidence to children! 12 months old and the associated
high mortality support the study of an early 2-dose measles vaccine regimen. Methods. Fifty …

[PDF][PDF] Humoral and Cell-Mediated Immune Responses to an Early 2-Dose Measles Vaccination Regimen in the United States

HA Gans, LL Yasukawa, A Alderson… - The Journal of …, 2004 - researchgate.net
Background. Shifts in peak measles incidence to children! 12 months old and the associated
high mortality support the study of an early 2-dose measles vaccine regimen. Methods. Fifty …

[PDF][PDF] Humoral and Cell-Mediated Immune Responses to an Early 2-Dose Measles Vaccination Regimen in the United States

HA Gans, LL Yasukawa, A Alderson, M Rinki… - The Journal of Infectious …, 2004 - Citeseer
Background. Shifts in peak measles incidence to children! 12 months old and the associated
high mortality support the study of an early 2-dose measles vaccine regimen. Methods. Fifty …